Kawasaki Disease
Symptoms, Doctors, Treatments, Advances & More

Learn About Kawasaki Disease

What is the definition of Kawasaki Disease?

Kawasaki disease is a sudden and time-limited (acute) illness that affects infants and young children. Affected children develop a prolonged fever lasting several days, a skin rash, and swollen lymph nodes in the neck (cervical lymphadenopathy). They also develop redness in the whites of the eyes (conjunctivitis) and redness (erythema) of the lips, lining of the mouth (oral mucosa), tongue, palms of the hands, and soles of the feet.

What are the causes of Kawasaki Disease?

The causes of Kawasaki disease are not well understood. The disorder is generally regarded as being the result of an abnormal immune system activation, but the triggers of this abnormal response are unknown. Because cases of the disorder tend to cluster geographically and by season, researchers have suggested that an infection may be involved. However, no infectious agent (such as a virus or bacteria) has been identified.

How prevalent is Kawasaki Disease?

In the United States and other Western countries, Kawasaki disease occurs in approximately 1 in 10,000 children under 5 each year. The condition is 10 to 20 times more common in East Asia, including Japan, Korea, and Taiwan.

Is Kawasaki Disease an inherited disorder?

A predisposition to Kawasaki disease appears to be passed through generations in families, but the inheritance pattern is unknown. Children of parents who have had Kawasaki disease have twice the risk of developing the disorder compared to the general population. Children with affected siblings have a tenfold higher risk.

Who are the top Kawasaki Disease Local Doctors?
Elite in Kawasaki Disease
Pediatric Cardiology
Elite in Kawasaki Disease
Pediatric Cardiology

Seattle Children's Hospital

4800 Sand Point Way NE, 
Seattle,, WA 
Languages Spoken:
English
Offers Telehealth

Michael Portman is a Pediatric Cardiologist in Seattle,, Washington. Dr. Portman is rated as an Elite provider by MediFind in the treatment of Kawasaki Disease. His top areas of expertise are Kawasaki Disease, Multisystem Inflammatory Syndrome in Children (MIS-C), Coronary Artery Aneurysm, and Pediatric Myocarditis.

Elite in Kawasaki Disease
Pediatric Cardiology
Elite in Kawasaki Disease
Pediatric Cardiology

Mount Sinai

1468 Madison Ave, 
New York, NY 
Languages Spoken:
English

Nadine Choueiter is a Pediatric Cardiologist in New York, New York. Dr. Choueiter is rated as an Elite provider by MediFind in the treatment of Kawasaki Disease. Her top areas of expertise are Kawasaki Disease, Coronary Artery Aneurysm, Multisystem Inflammatory Syndrome in Children (MIS-C), and Vasculitis.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Kawasaki Disease
Pediatric Cardiology
Elite in Kawasaki Disease
Pediatric Cardiology

Boston Children's Hospital

300 Longwood Ave, 
Boston, MA 
Languages Spoken:
English

Kevin Friedman is a Pediatric Cardiologist in Boston, Massachusetts. Dr. Friedman is rated as an Elite provider by MediFind in the treatment of Kawasaki Disease. His top areas of expertise are Coronary Artery Aneurysm, Kawasaki Disease, Multisystem Inflammatory Syndrome in Children (MIS-C), Embolectomy, and Heart Transplant.

What are the latest Kawasaki Disease Clinical Trials?
Kawasaki MATCH: A Clinical Decision Support Tool to Detect KD

Summary: Evaluating the impact of a machine-learning clinical decision support tool on provider practice when evaluating febrile patients with Kawasaki Disease (KD) and non-KD illnesses.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Comparison and Performance of Kobayashi and Kawanet IVIg Resistance Scores in a Multi-centric European and North Indian Cohort of KaWasaki dIsease (the KIWI Study)

Summary: Kawasaki disease (KD) is currently the leading cause of acquired heart diseases in children in developed countries. Cardiac involvement is the main determinant of the long-term prognosis of these patients, as coronary aneurisms (CAAs) may lead to ischemic heart disease and even sudden death. The current standard of care for KD has consistently reduced CAAs frequency from 25-30% to about 5%. Unfort...

Who are the sources who wrote this article ?

Published Date: September 01, 2015
Published By: National Institutes of Health